Page last updated: 2024-11-07

methylprednisolone acetate and Day Blindness

methylprednisolone acetate has been researched along with Day Blindness in 3 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ober, MD1
Del Priore, LV1
Tsai, J1
Lopez, R1
Lobes, LA1
Puklin, JE1
Young, T1
Cousins, MJ1
Andrew, NC1
Gregor, ZJ1

Other Studies

3 other studies available for methylprednisolone acetate and Day Blindness

ArticleYear
Diagnostic and therapeutic challenges.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:4

    Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Cardiomyopathies; Epoetin Alfa; Erythropoietin; Fluore

2006
An additional dimension to the efficacy of epidural steroids.
    Anesthesiology, 2000, Volume: 93, Issue:2

    Topics: Anti-Inflammatory Agents; Arterioles; Deafness; Humans; Injections, Epidural; Methylprednisolone; Me

2000
Intraocular injection of depomedrone.
    The British journal of ophthalmology, 1986, Volume: 70, Issue:4

    Topics: Aged; Anti-Inflammatory Agents; Electroretinography; Female; Humans; Injections; Methylprednisolone;

1986